Since 1992 the Department of Defense (DOD), through the U.S. Army Medical Research and Material Command, has received congressionally earmarked appropriations for programs of biomedical research on prostate, breast, and ovarian cancer; neurofibromatosis; tuberous sclerosis; and other health problems. Appropriations for these Congressionally Directed Medical Research Programs are used to support peer reviewed extramural research project, training, and infrastructure grants. Congress has become concerned about funding increases for these programs given current demands on the military budget. At the request of Congress, the Institute of Medicine (IOM) examined possibilities of augmenting program funding from alternative sources. The resulting IOM book, Strategies to Leverage Research Funding: Guiding DODa (TM)s Peer Reviewed Medical Research Programs, focuses on nonfederal and private sector contributions that could extend the appropriated funds without biasing the peer review project selection process.
Michael McGeary and Kathi E. Hanna, Editors, Committee on Alternative Funding Strategies for DOD's Peer Reviewed Medical Research Programs
1 Front Matter; 2 Executive Summary; 3 1 Introduction; 4 2 Sources of Funding for Biomedical Research; 5 3 Examples of Leveraging Nonfederal Dollars for Research; 6 4 Assessment of Alternative Sources and Mechanisms of Nonfederal Support; 7 5 Findings and Recommendations; 8 Appendix A: Selected Federal Programs with Nonfederal Funding Participation; 9 Appendix B: Biographical Sketches of Committee Members; 10 Appendix C: Workshop Agenda; 11 Appendix D: "Leveraging Public Investments with Private Sector Partnerships: A Review of the Economics Literature"
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Andrew Pope, Peter Bouxsein, Frederick J. Manning, Kathi E. Hanna
Institute of Medicine, Committee on Assessing the System for Protecting Human Research Participants, Laura Lyman Rodriguez, Kathi E. Hanna, Daniel D. Federman
National Research Council, Policy and Global Affairs, and Law Committee on Science, Technology, Committee on Daubert Standards, Anne-Marie Mazza, Kathi E. Hanna
Institute of Medicine, Board on Health Sciences Policy, Committee on Medical Preparedness for a Terrorist Nuclear Event, Susan R. McCutchen, Michael McGeary, Georges C. Benjamin
Institute of Medicine, Board on Health Sciences Policy, Committee for Assessment of NIH Centers of Excellence Programs, Ronald Estabrook, Michael McGeary, Frederick J. Manning
Institute of Medicine, Medical Follow-Up Agency, Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System, Richard N. Miller, Heather C. O'Maonaigh, Philip S. Brachman
Institute of Medicine, Medical Follow-Up Agency, Committee on U.S. Military Malaria Vaccine Research: A Program Review, Myron M. Levine, Patricia M. Graves